an increasing trendp<0.05
In vivo selvigaltin treatments showed an increasing trend across all doses, with the highest value observed at 0.3 mg/kg (55.51 ± 8.04; p<0.05 vs both RD+Veh and HFD+Veh).
In vivo selvigaltin treatments showed an increasing trend across all doses, with the highest value observed at 0.3 mg/kg (55.51 ± 8.04; p<0.05 vs both RD+Veh and HFD+Veh).
While SDH activity showed a significant change in the HFD+Veh group, normalized by higher doses of selvigaltin, ATP production did not quite reach statistical significance.